Liver fibrosis analysis using digital pathology.

Area of Science:

• Pathology
• Medical Imaging
• Artificial Intelligence

Background:

• Fibrosis is a critical marker of chronic inflammation in liver diseases.
• Accurate fibrosis evaluation is essential for predicting prognosis and hepatocarcinogenesis.
• Digital pathology and AI offer advanced tools for noninvasive pathological parameter quantification.

Purpose of the Study:

• To review the role of digital pathology in evaluating liver fibrosis.
• To discuss recent advancements in fibrosis assessment methods.
• To highlight the impact of AI in analyzing pathological data for liver disease.

Main Methods:

• Quantitative analysis of fibrotic parameters using digital pathology.
• Integration of artificial intelligence for large-scale data analysis.
• Review of established and emerging fibrosis evaluation techniques.

Main Results:

• Digital pathology enables noninvasive, quantitative assessment of fibrosis.
• AI combined with digital pathology facilitates information sharing and reduces knowledge gaps.
• Quantitative fibrosis evaluation predicts liver disease prognosis and cancer development.

Conclusions:

• Digital pathology and AI significantly improve the evaluation of liver fibrosis.
• Advanced methods like SHG/TPE microscopy and Fibronest™ offer novel approaches.
• This technology integration is crucial for managing chronic liver diseases effectively.